{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:43:03Z","timestamp":1793256183747,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,9,19]],"date-time":"2016-09-19T00:00:00Z","timestamp":1474243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,9,19]],"date-time":"2016-09-19T00:00:00Z","timestamp":1474243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Microbiol"],"DOI":"10.1038\/nmicrobiol.2016.164","type":"journal-article","created":{"date-parts":[[2016,9,19]],"date-time":"2016-09-19T13:51:38Z","timestamp":1474293098000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity"],"prefix":"10.1038","volume":"1","author":[{"given":"Kuan Rong","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7974-5288","authenticated-orcid":false,"given":"Wilfried A. A.","family":"Saron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther Shuyi","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwee Cheng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren Z. L.","family":"Mok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Summer Li-Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yie Hou","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Wijaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7601-165X","authenticated-orcid":false,"given":"Sujoy","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin Bun","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Tannenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soman N.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley L.","family":"St John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny G. H.","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eng Eong","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,19]]},"reference":[{"key":"BFnmicrobiol2016164_CR1","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1086\/652860","volume":"50","author":"BL Pike","year":"2010","unstructured":"Pike, B. L. et al. The origin and prevention of pandemics. Clin. Infect. Dis. 50, 1636\u20131640 (2010).","journal-title":"Clin. Infect. Dis."},{"key":"BFnmicrobiol2016164_CR2","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1056\/NEJMp1600297","volume":"374","author":"AS Fauci","year":"2016","unstructured":"Fauci, A. S. & Morens, D. M. Zika virus in the Americas\u2014yet another arbovirus threat. N. Engl. J. Med. 374, 601\u2013604 (2016).","journal-title":"N. Engl. J. Med."},{"key":"BFnmicrobiol2016164_CR3","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1056\/NEJMoa1411100","volume":"371","author":"WHO Ebola Response Team.","year":"2014","unstructured":"WHO Ebola Response Team. Ebola virus disease in West Africa\u2014the first 9 months of the epidemic and forward projections. N. Engl. J. Med. 371, 1481\u20131495 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFnmicrobiol2016164_CR4","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.immuni.2010.10.011","volume":"33","author":"DA D'Argenio","year":"2010","unstructured":"D'Argenio, D. A. & Wilson, C. B. A decade of vaccines: integrating immunology and vaccinology for rational vaccine design. Immunity 33, 437\u2013440 (2010).","journal-title":"Immunity"},{"key":"BFnmicrobiol2016164_CR5","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/nri3085","volume":"11","author":"R Rappuoli","year":"2011","unstructured":"Rappuoli, R., Mandl, C. W., Black, S. & De Gregorio, E. Vaccines for the twenty-first century society. Nat. Rev. Immunol. 11, 865\u2013872 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnmicrobiol2016164_CR6","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","volume":"386","author":"AM Henao-Restrepo","year":"2015","unstructured":"Henao-Restrepo, A. M. et al. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet 386, 857\u2013866 (2015).","journal-title":"Lancet"},{"key":"BFnmicrobiol2016164_CR7","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","volume":"372","author":"SP Buchbinder","year":"2008","unstructured":"Buchbinder, S. P. et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372, 1881\u20131893 (2008).","journal-title":"Lancet"},{"key":"BFnmicrobiol2016164_CR8","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1084\/jem.98.6.641","volume":"98","author":"FM Davenport","year":"1953","unstructured":"Davenport, F. M., Hennessy, A. V. & Francis, T. Jr Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus. J. Exp. Med. 98, 641\u2013656 (1953).","journal-title":"J. Exp. Med."},{"key":"BFnmicrobiol2016164_CR9","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","volume":"373","author":"SR Hadinegoro","year":"2015","unstructured":"Hadinegoro, S. R. et al. Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. N. Engl. J. Med. 373, 1195\u20131206 (2015).","journal-title":"N. Engl. J. Med."},{"key":"BFnmicrobiol2016164_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1056\/NEJMoa1411037","volume":"372","author":"L Villar","year":"2015","unstructured":"Villar, L. et al. Efficacy of a tetravalent dengue vaccine in children in Latin America. N. Engl. J. Med. 372, 113\u2013123 (2015).","journal-title":"N. Engl. J. Med."},{"key":"BFnmicrobiol2016164_CR11","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","volume":"384","author":"MR Capeding","year":"2014","unstructured":"Capeding, M. R. et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. Lancet 384, 1358\u20131365 (2014).","journal-title":"Lancet"},{"key":"BFnmicrobiol2016164_CR12","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/S1473-3099(10)70166-3","volume":"10","author":"SB Halstead","year":"2010","unstructured":"Halstead, S. B., Mahalingam, S., Marovich, M. A., Ubol, S. & Mosser, D. M. Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect. Dis. 10, 712\u2013722 (2010).","journal-title":"Lancet Infect. Dis."},{"key":"BFnmicrobiol2016164_CR13","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1073\/pnas.1317454111","volume":"111","author":"KR Chan","year":"2014","unstructured":"Chan, K. R. et al. Leukocyte immunoglobulin-like receptor B1 is critical for antibody-dependent dengue. Proc. Natl Acad. Sci. USA 111, 2722\u20132727 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnmicrobiol2016164_CR14","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1128\/JVI.00220-10","volume":"85","author":"K Boonnak","year":"2011","unstructured":"Boonnak, K., Dambach, K. M., Donofrio, G. C., Tassaneetrithep, B. & Marovich, M. A. Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection. J. Virol. 85, 1671\u20131683 (2011).","journal-title":"J. Virol."},{"key":"BFnmicrobiol2016164_CR15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/1471-2334-14-391","volume":"14","author":"AC Campi-Azevedo","year":"2014","unstructured":"Campi-Azevedo, A. C. et al. Subdoses of 17DD yellow fever vaccine elicit equivalent virological\/immunological kinetics timeline. BMC Infect. Dis. 14, 391 (2014).","journal-title":"BMC Infect. Dis."},{"key":"BFnmicrobiol2016164_CR16","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnmicrobiol2016164_CR17","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1084\/jem.20082292","volume":"205","author":"D Gaucher","year":"2008","unstructured":"Gaucher, D. et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J. Exp. Med. 205, 3119\u20133131 (2008).","journal-title":"J. Exp. Med."},{"key":"BFnmicrobiol2016164_CR18","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/ni.1688","volume":"10","author":"TD Querec","year":"2009","unstructured":"Querec, T. D. et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat. Immunol. 10, 116\u2013125 (2009).","journal-title":"Nat. Immunol."},{"key":"BFnmicrobiol2016164_CR19","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nature14468","volume":"523","author":"EF McKinney","year":"2015","unstructured":"McKinney, E. F., Lee, J. C., Jayne, D. R., Lyons, P. A. & Smith, K. G. T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection. Nature 523, 612\u2013616 (2015).","journal-title":"Nature"},{"key":"BFnmicrobiol2016164_CR20","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/nri1248","volume":"3","author":"O Acuto","year":"2003","unstructured":"Acuto, O. & Michel, F. CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nat. Rev. Immunol. 3, 939\u2013951 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnmicrobiol2016164_CR21","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nri3156","volume":"12","author":"O Boyman","year":"2012","unstructured":"Boyman, O. & Sprent, J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat. Rev. Immunol. 12, 180\u2013190 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnmicrobiol2016164_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ni1553","volume":"9","author":"K Suzuki","year":"2008","unstructured":"Suzuki, K., Kumanogoh, A. & Kikutani, H. Semaphorins and their receptors in immune cell interactions. Nat. Immunol. 9, 17\u201323 (2008).","journal-title":"Nat. Immunol."},{"key":"BFnmicrobiol2016164_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.it.2012.01.008","volume":"33","author":"H Takamatsu","year":"2012","unstructured":"Takamatsu, H. & Kumanogoh, A. Diverse roles for semaphorin-plexin signaling in the immune system. Trends Immunol. 33, 127\u2013135 (2012).","journal-title":"Trends Immunol."},{"key":"BFnmicrobiol2016164_CR24","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/0092-8674(93)90625-Z","volume":"75","author":"AL Kolodkin","year":"1993","unstructured":"Kolodkin, A. L., Matthes, D. J. & Goodman, C. S. The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules. Cell 75, 1389\u20131399 (1993).","journal-title":"Cell"},{"key":"BFnmicrobiol2016164_CR25","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nature01037","volume":"419","author":"A Kumanogoh","year":"2002","unstructured":"Kumanogoh, A. et al. Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2. Nature 419, 629\u2013633 (2002).","journal-title":"Nature"},{"key":"BFnmicrobiol2016164_CR26","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/nature05652","volume":"446","author":"K Suzuki","year":"2007","unstructured":"Suzuki, K. et al. Semaphorin 7A initiates T-cell-mediated inflammatory responses through \u03b11\u03b21 integrin. Nature 446, 680\u2013684 (2007).","journal-title":"Nature"},{"key":"BFnmicrobiol2016164_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.4049\/jimmunol.1403096","volume":"196","author":"A van Rijn","year":"2016","unstructured":"van Rijn, A. et al. Semaphorin 7A promotes chemokine-driven dendritic cell migration. J. Immunol. 196, 459\u2013468 (2016).","journal-title":"J. Immunol."},{"key":"BFnmicrobiol2016164_CR28","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1084\/jem.174.6.1323","volume":"174","author":"RA Daynes","year":"1991","unstructured":"Daynes, R. A., Dowell, T. & Araneo, B. A. Platelet-derived growth factor is a potent biologic response modifier of T cells. J. Exp. Med. 174, 1323\u20131333 (1991).","journal-title":"J. Exp. Med."},{"key":"BFnmicrobiol2016164_CR29","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/bjc.2012.468","volume":"107","author":"NG Gavalas","year":"2012","unstructured":"Gavalas, N. G. et al. VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2. Br. J. Cancer 107, 1869\u20131875 (2012).","journal-title":"Br. J. Cancer"},{"key":"BFnmicrobiol2016164_CR30","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/ijc.26094","volume":"130","author":"AC Ziogas","year":"2012","unstructured":"Ziogas, A. C. et al. VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2. Int. J. Cancer 130, 857\u2013864 (2012).","journal-title":"Int. J. Cancer"},{"key":"BFnmicrobiol2016164_CR31","doi-asserted-by":"publisher","first-page":"8440","DOI":"10.4049\/jimmunol.177.12.8440","volume":"177","author":"Y Liu","year":"2006","unstructured":"Liu, Y. et al. Regulated expression of FcgammaR in human dendritic cells controls cross-presentation of antigen-antibody complexes. J. Immunol. 177, 8440\u20138447 (2006).","journal-title":"J. Immunol."},{"key":"BFnmicrobiol2016164_CR32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4269\/ajtmh.1990.42.179","volume":"42","author":"MG Guzman","year":"1990","unstructured":"Guzman, M. G. et al. Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am. J. Trop. Med. Hyg. 42, 179\u2013184 (1990).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"BFnmicrobiol2016164_CR33","doi-asserted-by":"publisher","first-page":"e1004386","DOI":"10.1371\/journal.ppat.1004386","volume":"10","author":"R de Alwis","year":"2014","unstructured":"de Alwis, R. et al. Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera. PLoS Pathogens 10, e1004386 (2014).","journal-title":"PLoS Pathogens"},{"key":"BFnmicrobiol2016164_CR34","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1084\/jem.146.1.201","volume":"146","author":"SB Halstead","year":"1977","unstructured":"Halstead, S. B. & O'Rourke, E. J. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J. Exp. Med. 146, 201\u2013217 (1977).","journal-title":"J. Exp. Med."},{"key":"BFnmicrobiol2016164_CR35","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/infdis\/jit273","volume":"208","author":"S Olkowski","year":"2013","unstructured":"Olkowski, S. et al. Reduced risk of disease during postsecondary dengue virus infections. J. Infect. Dis. 208, 1026\u20131033 (2013).","journal-title":"J. Infect. Dis."},{"key":"BFnmicrobiol2016164_CR36","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/s12879-015-1150-2","volume":"15","author":"V Thanachartwet","year":"2015","unstructured":"Thanachartwet, V. et al. Identification of clinical factors associated with severe dengue among Thai adults: a prospective study. BMC Infect. Dis. 15, 420 (2015).","journal-title":"BMC Infect. Dis."},{"key":"BFnmicrobiol2016164_CR37","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1172\/JCI74572","volume":"124","author":"S Ben Mkaddem","year":"2014","unstructured":"Ben Mkaddem, S. et al. Shifting Fc\u03b3RIIA-ITAM from activation to inhibitory conFig.uration ameliorates arthritis. J. Clin. Invest. 124, 3945\u20133959 (2014).","journal-title":"J. Clin. Invest."},{"key":"BFnmicrobiol2016164_CR38","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1182\/blood-2011-08-376046","volume":"119","author":"M Aloulou","year":"2012","unstructured":"Aloulou, M. et al. IgG1 and IVIg induce inhibitory ITAM signaling through Fc\u03b3RIII controlling inflammatory responses. Blood 119, 3084\u20133096 (2012).","journal-title":"Blood"},{"key":"BFnmicrobiol2016164_CR39","doi-asserted-by":"publisher","first-page":"12479","DOI":"10.1073\/pnas.1106568108","volume":"108","author":"KR Chan","year":"2011","unstructured":"Chan, K. R. et al. Ligation of Fc \u03b3 receptor IIB inhibits antibody-dependent enhancement of dengue virus infection. Proc. Natl Acad. Sci. USA 108, 12479\u201312484 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnmicrobiol2016164_CR40","doi-asserted-by":"crossref","first-page":"621","DOI":"10.4049\/jimmunol.147.2.621","volume":"147","author":"MR Lennartz","year":"1991","unstructured":"Lennartz, M. R. & Brown, E. J. Arachidonic acid is essential for IgG Fc receptor-mediated phagocytosis by human monocytes. J. Immunol. 147, 621\u2013626 (1991).","journal-title":"J. Immunol."},{"key":"BFnmicrobiol2016164_CR41","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s11745-007-3072-2","volume":"42","author":"E Stachowska","year":"2007","unstructured":"Stachowska, E. et al. Conjugated linoleic acids can change phagocytosis of human monocytes\/macrophages by reduction in Cox-2 expression. Lipids 42, 707\u2013716 (2007).","journal-title":"Lipids"},{"key":"BFnmicrobiol2016164_CR42","doi-asserted-by":"publisher","first-page":"265","DOI":"10.4049\/jimmunol.176.1.265","volume":"176","author":"MK Middleton","year":"2006","unstructured":"Middleton, M. K., Rubinstein, T. & Pure, E. Cellular and molecular mechanisms of the selective regulation of IL-12 production by 12\/15-lipoxygenase. J. Immunol. 176, 265\u2013274 (2006).","journal-title":"J. Immunol."},{"key":"BFnmicrobiol2016164_CR43","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1038\/sj.ejcn.1601478","volume":"56","author":"PC Calder","year":"2002","unstructured":"Calder, P. C. & Grimble, R. F. Polyunsaturated fatty acids, inflammation and immunity. Eur. J. Clin. Nutr. 56(Suppl. 3), S14\u2013S19 (2002).","journal-title":"Eur. J. Clin. Nutr."},{"key":"BFnmicrobiol2016164_CR44","doi-asserted-by":"publisher","first-page":"12300","DOI":"10.1073\/pnas.1400476111","volume":"111","author":"B Pulendran","year":"2014","unstructured":"Pulendran, B. Systems vaccinology: probing humanity's diverse immune systems with vaccines. Proc. Natl Acad. Sci. USA 111, 12300\u201312306 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnmicrobiol2016164_CR45","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1146\/annurev-genom-091212-153448","volume":"14","author":"JL Casanova","year":"2013","unstructured":"Casanova, J. L. & Abel, L. The genetic theory of infectious diseases: a brief history and selected illustrations. Annu. Rev. Genom. Hum. Genet. 14, 215\u2013243 (2013).","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"BFnmicrobiol2016164_CR46","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature10213","volume":"474","author":"AL Kau","year":"2011","unstructured":"Kau, A. L., Ahern, P. P., Griffin, N. W., Goodman, A. L. & Gordon, J. I. Human nutrition, the gut microbiome and the immune system. Nature 474, 327\u2013336 (2011).","journal-title":"Nature"},{"key":"BFnmicrobiol2016164_CR47","doi-asserted-by":"publisher","first-page":"26100","DOI":"10.1038\/srep26100","volume":"6","author":"KC Goh","year":"2016","unstructured":"Goh, K. C. et al. Molecular determinants of plaque size as an indicator of dengue virus attenuation. Sci. Rep. 6, 26100 (2016).","journal-title":"Sci. Rep."},{"key":"BFnmicrobiol2016164_CR48","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1126\/science.1255006","volume":"345","author":"H Jafari","year":"2014","unstructured":"Jafari, H. et al. Polio eradication. Efficacy of inactivated poliovirus vaccine in India. Science 345, 922\u2013925 (2014).","journal-title":"Science"},{"key":"BFnmicrobiol2016164_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/jama.1976.03260270017018","volume":"235","author":"JW Bass","year":"1976","unstructured":"Bass, J. W. et al. Booster vaccination with further live attenuated measles vaccine. JAMA 235, 31\u201334 (1976).","journal-title":"JAMA"},{"key":"BFnmicrobiol2016164_CR50","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13063-015-0651-z","volume":"16","author":"JG Low","year":"2015","unstructured":"Low, J. G. et al. The role of pre-existing cross-reactive antibodies in determining the efficacy of vaccination in humans: study protocol for a randomized controlled trial. Trials 16, 147 (2015).","journal-title":"Trials"},{"key":"BFnmicrobiol2016164_CR51","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.1128\/JCM.01799-12","volume":"50","author":"C Domingo","year":"2012","unstructured":"Domingo, C. et al. Advanced yellow fever virus genome detection in point-of-care facilities and reference laboratories. J. Clin. Microbiol. 50, 4054\u20134060 (2012).","journal-title":"J. Clin. Microbiol."},{"key":"BFnmicrobiol2016164_CR52","doi-asserted-by":"publisher","first-page":"e2373","DOI":"10.1371\/journal.pntd.0002373","volume":"7","author":"L Cui","year":"2013","unstructured":"Cui, L. et al. Serum metabolome and lipidome changes in adult patients with primary dengue infection. PLoS Negl. Trop. Dis. 7, e2373 (2013).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"BFnmicrobiol2016164_CR53","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/1465-9921-7-126","volume":"7","author":"BJ Hanson","year":"2006","unstructured":"Hanson, B. J. et al. Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice. Respir. Res. 7, 126 (2006).","journal-title":"Respir. Res."}],"container-title":["Nature Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nmicrobiol2016164.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nmicrobiol2016164","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nmicrobiol2016164.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T22:37:17Z","timestamp":1733956637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nmicrobiol2016164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,19]]},"references-count":53,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12]]}},"alternative-id":["BFnmicrobiol2016164"],"URL":"https:\/\/doi.org\/10.1038\/nmicrobiol.2016.164","relation":{},"ISSN":["2058-5276"],"issn-type":[{"value":"2058-5276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,19]]},"assertion":[{"value":"14 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16164"}}